Tolterodine Tartrate
- Product NDC
- 0093-2049
- 11-digit product format
- 000932049
- Labeler code
- 0093
- Product ID
- 0093-2049_95042583-c90a-40a9-98e1-bdd849df6e8b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tolterodine Tartrate
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA Inc
- Application
- NDA021228
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2014-01-02
- Marketing end
- 0000-00-00
- Substance
- TOLTERODINE TARTRATE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 0093-2049 | D | Discontinued by firm | 2026-07-31 | ||
| excluded package | package | 0093-2049 | 0093-2049-05 | D | Discontinued by firm | 2026-07-31 | |
| excluded package | package | 0093-2049 | 0093-2049-56 | D | Discontinued by firm | 2026-07-31 | |
| excluded package | package | 0093-2049 | 0093-2049-98 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021228-001 | DETROL LA | TOLTERODINE TARTRATE | 2MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2000-12-22 |
| N021228-002 | DETROL LA | TOLTERODINE TARTRATE | 4MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2000-12-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021228-001 | AB |
| N021228-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N021228-001 | DETROL LA | 2MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2000-12-22 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021228-002 | DETROL LA | 4MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2000-12-22 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N021228-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021228-002 | AB | 1 | a50c72e98297… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b480943b-5b5a-aac0-c5ca-c22f479ac1a1 | Product name | 8 | 20250325 |
| a932c194-3a9e-a7d8-8961-eb5843129c16 | Product name | 6 | 20220210 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0093-2049-05 | EA - Each | 0093-2049 | df7db28b-cd44-454a-9e03-ea36c7df4e4e | 1 | 2014-02-04 |
| 0093-2049-56 | EA - Each | 0093-2049 | 32475ba6-16d6-4c83-b932-890aa92d5d43 | 1 | 2014-02-04 |
| 0093-2049-98 | EA - Each | 0093-2049 | 7cc1badd-bef1-4908-9c04-61df702f3299 | 1 | 2014-02-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| TOLTERODINE TARTRATE | ACTIVE INGREDIENT | 5T619TQR3R | TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] | 5 | |
| TOLTERODINE | ACTIVE MOIETY | WHE7A56U7K | TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] | 5 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 855182 | tolterodine tartrate 2 MG 24HR Extended Release Oral Capsule | PSN | 09b4ec42-9b47-4a6c-b219-7c5dcda35ac5 | 4 |
| 855189 | tolterodine tartrate 4 MG 24HR Extended Release Oral Capsule | PSN | 09b4ec42-9b47-4a6c-b219-7c5dcda35ac5 | 4 |
| 855182 | 24 HR tolterodine tartrate 2 MG Extended Release Oral Capsule | SCD | 09b4ec42-9b47-4a6c-b219-7c5dcda35ac5 | 4 |
| 855189 | 24 HR tolterodine tartrate 4 MG Extended Release Oral Capsule | SCD | 09b4ec42-9b47-4a6c-b219-7c5dcda35ac5 | 4 |
| 855182 | tolterodine tartrate 2 MG 24 HR Extended Release Oral Capsule | SY | 09b4ec42-9b47-4a6c-b219-7c5dcda35ac5 | 4 |
| 855189 | tolterodine tartrate 4 MG 24 HR Extended Release Oral Capsule | SY | 09b4ec42-9b47-4a6c-b219-7c5dcda35ac5 | 4 |
| 855189 | tolterodine tartrate 4 MG 24HR Extended Release Oral Capsule | PSN | ca4b3a0e-0f80-44e7-8cad-587610c6f198 | 2 |
| 855189 | 24 HR tolterodine tartrate 4 MG Extended Release Oral Capsule | SCD | ca4b3a0e-0f80-44e7-8cad-587610c6f198 | 2 |
| 855189 | tolterodine tartrate 4 MG 24 HR Extended Release Oral Capsule | SY | ca4b3a0e-0f80-44e7-8cad-587610c6f198 | 2 |